Insider · CIK 0001216628

HILLEMAN JERYL L

Reports to the SEC for 12 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001216628

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,214 sh	—	—	27,869
2026-07-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,435 sh	—	—	26,655
2026-07-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,299 sh	—	—	26,519
2026-06-16	OMDAOmada Health, Inc.A Award	Director	AAward	+10.9K sh	—	—	25,220
2026-06-04	SIBNSI-BONE, Inc.A Award	Director	AAward	+11K sh	—	—	43,772
2026-06-03	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,999
2026-06-03	NVCRNovoCure LtdA Award	Director	AAward	+11.6K sh	—	—	25,471
2026-06-02	NVCRNovoCure LtdS Sale	Director	SSale	−2,945 sh	$15.77	−$46.4K	13,861
2026-04-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,544 sh	—	—	14,338
2026-01-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,601 sh	—	—	12,794
2025-10-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,126 sh	—	—	11,238
2025-10-05	OMDAOmada Health, Inc.A Award	Director	AAward	+1,081 sh	—	—	11,193
2025-09-17	HilleVax, Inc.U Disposition from Tender	Director	UDisposition from Tender	−59.2K sh	—	—	0
2025-07-05	OMDAOmada Health, Inc.A Award	Director	AAward	+376 sh	—	—	10,112
2025-06-23	HilleVax, Inc.A Award	Director	AAward	+17.2K sh	—	—	59,224
2025-06-05	OMDAOmada Health, Inc.A Award	Director	AAward	+9,736 sh	—	—	9,736
2025-06-05	SIBNSI-BONE, Inc.A Award	Director	AAward	+8,675 sh	—	—	32,815
2025-06-04	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+16.7K sh	—	—	16,697
2025-06-04	NVCRNovoCure LtdA Award	Director	AAward	+11.2K sh	—	—	16,806
2025-06-03	NVCRNovoCure LtdS Sale	Director	SSale	−999 sh	$17.26	−$17.2K	5,591
2024-10-24	CUTERA INCStock Option (Right to Buy)A Award	Director	AAward	+14.7K sh	—	—	40,000
2024-07-12	CUTERA INCStock Option (Right to Buy)A Award	Director	AAward	+25.3K sh	—	—	25,327
2024-06-26	SIBNSI-BONE, Inc.A Award	Director	AAward	+8,791 sh	—	—	24,140
2024-06-06	HilleVax, Inc.Stock OptionA Award	Director	AAward	+22.5K sh	—	—	22,500
2024-06-05	NVCRNovoCure LtdA Award	Director	AAward	+4,053 sh	—	—	6,590
2024-06-05	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+6,229 sh	—	—	6,229
2023-09-27	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2023-06-20	SIBNSI-BONE, Inc.S Sale	Director	SSale	−2,081 sh	$28.00	−$58.3K	15,349
2023-06-15	SIBNSI-BONE, Inc.S Sale	Director	SSale	−2,081 sh	$28.74	−$59.8K	17,430
2023-06-09	SIBNSI-BONE, Inc.A Award	Director	AAward	+4,866 sh	—	—	19,511
2023-06-07	HilleVax, Inc.Stock OptionA Award	Director	AAward	+22.5K sh	—	—	22,500
2023-06-07	NVCRNovoCure Ltd · Stock Option (Right to Buy)A Award	Director	AAward	+12.6K sh	—	—	12,554
2022-08-19	HilleVax, Inc.Stock OptionA Award	Director	AAward	+25K sh	—	—	25,000
2022-06-16	SIBNSI-BONE, Inc.A Award	Director	AAward	+8,324 sh	—	—	14,645
2022-06-13	SIBNSI-BONE, Inc.S Sale	Director	SSale	−1,924 sh	$13.81	−$26.6K	6,321
2022-06-10	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,500 sh	—	—	2,500
2022-06-10	NVCRNovoCure LtdS Sale	Director	SSale	−407 sh	$69.61	−$28.3K	2,537
2022-06-08	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+8,700 sh	—	—	8,700
2021-06-25	SIBNSI-BONE, Inc.S Sale	Director	SSale	−4,400 sh	$33.71	−$148K	8,245
2021-06-11	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2021-06-10	SIBNSI-BONE, Inc.A Award	Director	AAward	+3,848 sh	—	—	12,645
2021-06-09	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+1,499 sh	—	—	1,499
2021-06-09	NVCRNovoCure LtdD Disposition to Issuer	Director	DDisposition to Issuer	−1,270 sh	$210.01	−$267K	2,944
2021-06-09	NVCRNovoCure LtdA Award	Director	AAward	+814 sh	—	—	4,214
2021-03-16	TLISTalis Biomedical Corp · Stock Option (right to buy)A Award	Director	AAward	+35.1K sh	—	—	35,112
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−2,500 sh	$166.40	−$416K	3,400
2020-06-16	SIBNSI-BONE, Inc.A Award	Director	AAward	+8,797 sh	—	—	8,797
2020-06-11	NERVMinerva Neurosciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-10	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+5,101 sh	—	—	5,101
2020-06-10	NVCRNovoCure LtdA Award	Director	AAward	+2,541 sh	—	—	5,900

Recent filings

Accepted (ET)
Oct 7 16:144
HILLEMAN JERYL L0001610717-26-000428
SEC(opens sec.gov)
Jul 204/A
HILLEMAN JERYL L0001610717-26-000340
SEC(opens sec.gov)
Jul 74
HILLEMAN JERYL L0001610717-26-000324
SEC(opens sec.gov)
Jun 184
HILLEMAN JERYL L0001610717-26-000254
SEC(opens sec.gov)
Jun 94
HILLEMAN JERYL L0001216628-26-000003
SEC(opens sec.gov)
Jun 54
HILLEMAN JERYL L0001216628-26-000002
SEC(opens sec.gov)
Jun 34
HILLEMAN JERYL L0001216628-26-000001
SEC(opens sec.gov)
Apr 74
HILLEMAN JERYL L0001610717-26-000143
SEC(opens sec.gov)
Jan 74
HILLEMAN JERYL L0001610717-26-000004
SEC(opens sec.gov)
Dec 184/A
HILLEMAN JERYL L0001610717-25-000425
SEC(opens sec.gov)
Oct 74
HILLEMAN JERYL L0001628280-25-044510
SEC(opens sec.gov)
Sep 174
HILLEMAN JERYL L0001193125-25-206253
SEC(opens sec.gov)
Jul 84
HILLEMAN JERYL L0001610717-25-000281
SEC(opens sec.gov)
Jun 254
HILLEMAN JERYL L0000950170-25-089951
SEC(opens sec.gov)
Jun 94
HILLEMAN JERYL L0001610717-25-000178
SEC(opens sec.gov)
Jun 64
HILLEMAN JERYL L0001562180-25-004559
SEC(opens sec.gov)
Jun 64
HILLEMAN JERYL L0001562180-25-004610
SEC(opens sec.gov)
Jun 44
HILLEMAN JERYL L0001562180-25-004431
SEC(opens sec.gov)

Companies

Address

C/O OMADA HEALTH, INC. 611 GATEWAY BLVD., SUITE 120

SOUTH SAN FRANCISCO, CA, 94080